Introduction
Protein modifications
Folding
Chaperon mediated
Enzymatic
Cleavage
Addition of functional groups
Chemical groups
Hydrophobic groups
Proteolysis
Conclusion
Reference
Protein targeting or protein sorting is the mechanism by which a cell transports to the appropriate positions in the cell or outside of it. Both in prokaryotes and eukaryotes, newly synthesized proteins must be delivered to a specific sub-cellular location or exported from the cell for correct activity. This phenomenon is called protein targeting. Protein targeting is necessary for proteins that are destined to work outside the cytoplasm.This delivery process is carried out based on information contained in the protein itself. Correct sorting is crucial for the cell; errors can lead to diseases. In 1970, Günter Blobel conducted experiments on the translocation of proteins across membranes. He was awarded the 1999 Nobel Prize for his findings. He discovered that many proteins have a signal sequence, that is, a short amino acid sequence at one end that functions like a postal code for the target organelle.
Protein targeting or protein sorting is the biological mechanism by which proteins are transported to their appropriate destinations in the cell or outside it. Proteins can be targeted to the inner space of an organelle, different intracellular membranes, plasma membrane, or to exterior of the cell via secretion.
The delivery of newly synthesized protein to their proper cellular destination, usually referred to as protein targeting or sorting.
The mode of protein transport depends chiefly on the location in the cell cytoplasm of the polysomes involved in protein synthesis.
There are two modes of protein sorting:-
1) Co - translational Transportation.
2) Post - translational Transportation.
Introduction
History
Experiment of Ramachandran
Structure of protein
Primary structure
Secondary structure
Tertiary structure
Quaternary structure
Peptide bond is rigid & planar
Torsion angle (Φ and Ψ)
Ramachandran plot
For helices
For β strands
Significance of Ramachandran plot
Conclusion
Reference
Protein targeting or protein sorting is the mechanism by which a cell transports to the appropriate positions in the cell or outside of it. Both in prokaryotes and eukaryotes, newly synthesized proteins must be delivered to a specific sub-cellular location or exported from the cell for correct activity. This phenomenon is called protein targeting. Protein targeting is necessary for proteins that are destined to work outside the cytoplasm.This delivery process is carried out based on information contained in the protein itself. Correct sorting is crucial for the cell; errors can lead to diseases. In 1970, Günter Blobel conducted experiments on the translocation of proteins across membranes. He was awarded the 1999 Nobel Prize for his findings. He discovered that many proteins have a signal sequence, that is, a short amino acid sequence at one end that functions like a postal code for the target organelle.
Protein targeting or protein sorting is the biological mechanism by which proteins are transported to their appropriate destinations in the cell or outside it. Proteins can be targeted to the inner space of an organelle, different intracellular membranes, plasma membrane, or to exterior of the cell via secretion.
The delivery of newly synthesized protein to their proper cellular destination, usually referred to as protein targeting or sorting.
The mode of protein transport depends chiefly on the location in the cell cytoplasm of the polysomes involved in protein synthesis.
There are two modes of protein sorting:-
1) Co - translational Transportation.
2) Post - translational Transportation.
Introduction
History
Experiment of Ramachandran
Structure of protein
Primary structure
Secondary structure
Tertiary structure
Quaternary structure
Peptide bond is rigid & planar
Torsion angle (Φ and Ψ)
Ramachandran plot
For helices
For β strands
Significance of Ramachandran plot
Conclusion
Reference
Protein targeting or protein sorting is the biological mechanism by which proteins are transported to their appropriate destinations in the cell or outside it. Proteins can be targeted to the inner space of an organelle, different intracellular membranes, plasma membrane, or to exterior of the cell via secretion.
This presentation gives an overview of Lipid Rafts, how it was discovered, its importance and the future research in this area,Feel free to comment and ask any questions
Protein targeting or protein sorting is the biological mechanism by which proteins are transported to their appropriate destinations in the cell or outside it. Proteins can be targeted to the inner space of an organelle, different intracellular membranes, plasma membrane, or to exterior of the cell via secretion.
This presentation gives an overview of Lipid Rafts, how it was discovered, its importance and the future research in this area,Feel free to comment and ask any questions
Regulation of gene expression in eukariyotic organismsDhruviSuvagiya
Post-translational modification (PTM) refers to the covalent and generally enzymatic modification of proteins following protein biosynthesis. Proteins are synthesized by ribosomes translating mRNA into polypeptide chains, which may then undergo PTM to form the mature protein product. PTMs are important components in cell signaling, as for example when prohormones are converted to hormones.
Ubiquitin & Proteasome: Role in Transcription RegulationAnjali Dahiya
Eukaryotic gene transcription is a phenomenally complex process. Regulation of gene transcription is vitally important for the maintenance of normal cellular homeostasis. Failure to correctly regulate gene expression can lead to cellular catastrophe and disease. One of the ways, cells cope with the challenges of transcription is by making extensive use of the proteolytic and nonproteolytic activities of the ubiquitin proteasome system (UPS)
This file is all about protein, its composition, functions, metabolism, importance in body, degradation and ways involved, as well as secretion with post transitional changes
Introduction
History
Tumor suppressor gene- pRB
- RB gene
- Role of RB in regulation of cell cycle
- Tumor associated with RB gene mutation
Tumor suppressor gene- p53
- What is p53 gene?
- Function of p53 gene
- How it regulates cell cycle
- What happen if p53 gene inactivated
- Cancer associated with p53 mutation
- Conclusion
- References
Introduction
Definition
History
Two hit hypothesis
Functions
Mutation in tumor suppressor genes
What is mutation
Inherited mutation of TSGs
Acquired mutation of TSGs
What is Oncogenes?
TSGs and Oncogenes : Brakes and accelerators
Stop and go signal
Examples of TSGs:
RB-The retinoblastoma gene
P53 protein
TSGs &cell suicide
Conclusion
References
Introduction
Protein synthesis
Synthesis of secretory proteins on membrane-bound ribosomes
Processing of newly synthesized proteins in the ER
Synthesis of integral membrane protein on membrane bound ribosomes
Maintenance of membrane asymmetry
Conclusion
Reference
Introduction
Definition
Factors required for Translation
Formation of aminoacyl t-RNA
1)Activation of amino acid
2) Transfer of amino acid to t-RNA
Translation involves following steps:-
1)Initiation
2)Elongation
3)Termination
Conclusion
Reference
Introduction
Definition
History
central dogma
Major components
mRNA,tRNA,rRNA
Energy source
Amino acids
Protien factor
Enzymes
Inorganic ions
Step involves in translation:
Aminoacylation of tRNA
Initiation
Elongation
termination
Importance of translation
Conclusion
Reference
INTRODUCTION
HISTORY
WHAT IS TRANSCRIPTION
PROKARYOTIC TRANSCRIPTION
STEPS OF TRANSCRIPTION
HOW TRANSCRIPTION OCCURS
PROCESS OF TRANSCRIPTION
Initiation
Elongation
Termination
CONCLUSION
REFRENCES
Enzyme Kinetics and thermodynamic analysisKAUSHAL SAHU
Introduction
Kinetics and thermodynamicSG
Thermodynamic in enzymatic reactions
balanced equations in chemical reactions
changes in free energy determine the direction & equilibrium state of chemical reactions
the rates of reactions
Factors effecting enzymatic activity
(i) Enzyme concentration.
(ii) Substrate concentration.
(iii)Temperature
(iv) pH.
(v) Activators.
(vi)Inhibitors
Michaelis-menten equation
CONCLUSIONS
REFERENECES
Recepter mediated endocytosis by kk ashuKAUSHAL SAHU
INTRODUCTION
DEFINITION OF RECEPTOR MEDIATED ENDOCYTOSIS
WHAT TYPE OF LIGANDS ENTER BY RME?
FORMATION OF CLATHRIN-COATED VESICLES
TRISKELIONS
ROLE OF DYNAMIN IN THE FORMATION OF CLATHRIN-COATED VESICLES
ROLE OF PHOSPHOLIPIDS IN THE FORMATION OF COATED VESICLES
ENDOCYTIC PATHWAY
LDLs AND CHOLESTROL METABOLISM
CONCLUSION
REFERENCES
Prokaryotic translation machinery by kk KAUSHAL SAHU
Introduction
Definition
Factors required for Translation
Formation of aminoacyl t-RNA
1)Activation of amino acid
2) Transfer of amino acid to t-RNA
Translation involves following steps:-
1)Initiation
2)Elongation
3)Termination
Conclusion
Reference
INTRODUCTION.
HISTORY.
PROCESS OF TRANSCRIPTION.
STAGES OF TRANSCRIPTION.
ENZYME INVOLVES IN TRANSCRIPTION.
TERMINATION.
PROKARYOTES.
Transcription terminators.
EUKARYOTES.
Two models for termination.
CONCLUSION.
REFERENCES.
Transcription in eukariotes by kk sahuKAUSHAL SAHU
INTRODUCTION
A STRUCTURAL GENE
EUKARYOTIC RNAPs
MACHANISM OF TRANSCRIPTION IN EUKARYOTES:
- INITIATION
-ELONGATION
-TERMINATION
RNA SPLISING
DIFFERENT BETWEEN PROKARYOTIC & EUKARYOTIC TRANSCRIPTION
BIBLIOGRAPHY
RNA polymerase and transcription factorKAUSHAL SAHU
INTRODUCTION
WHAT IS TRANSCRIPTION ?
STEPS INVOLVE IN TRANSCRIPTION.
RNA POLYMERASES.
HISTORY OF RNA POLYMERASES.
STRUCTURE OF RNA POLYMERASES.
SUB UNITS OF RNA POLYMERASES.
TYPES OF RNA POLYMERASES.
FUNCTION OF RNA POLYMERASES.
TRANSCRIPTION FACTORS INVOLVE IN EUKARYOTIC TRANSCRIPTION.
CONCLUSION.
REFERENCES.
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
1. SEMINAR ON
CO & POST-TRANSLATIONAL MODIFICATION
CO & POST-TRANSLATIONAL MODIFICATION
By
KAUSHAL KUMAR SAHU
Assistant Professor (Ad Hoc)
Department of Biotechnology
Govt. Digvijay Autonomous P. G. College
Raj-Nandgaon ( C. G. )
2. CONTENTS:
Introduction
Protein modifications
Folding
• Chaperon mediated
• Enzymatic
Cleavage
Addition of functional groups
• Chemical groups
• Hydrophobic groups
Proteolysis
Conclusion
Reference
Co & Post Translational Modification
3. INTRODUCTION:
Protein modification can occur at any step in the "life cycle" of a
protein. For example, many proteins are modified shortly after
translation is completed to mediate proper protein folding or stability
or to direct the nascent protein to distinct cellular compartments .
Other modifications occur after folding and localization are
completed to activate or inactivate catalytic activity or to otherwise
influence the biological activity of the protein.
Co & Post Translational Modification
4.
5. PROTEIN MODIFICATIONS
I] Folding:
It is the physical process by which a polypeptide folds into its
characteristic and functional three-dimensional
structure from random coil.
The correct three-dimensional structure is essential to function,
although some parts of functional proteins may remain unfolded.
A] Chaperone Mediated:
The term `molecular chaperone` appeared first in the literature in
1978, and was invented by Ron Laskey.
There are many different families of chaperones; each family acts
to aid protein folding in a different way.
Co & Post Translational Modification
6. Family Size Location Example
Hsp 60 ~ 1 MDa Mitochondria,
Chloroplast
GroEL/GroES in
E.coli
Hsp 70 ~ 70 kDa Cytoplasm, ER
,
Mitochondria,
Chloroplast
DnaK in E.coli
Hsp 90 ~ 90 kDa ER, cytosol,
mitochondria
HtpG in E.coli
Hsp 100 ~ 100 kDa Mitochondria,
ER
chloroplast
Clp in E.coli
Co & Post Translational Modification
7. Co & Post Translational Modification
Fig: Model of bacterial chaperones
involved in protein folding
Fig: Model of eukaryotic chaperones
involved in protein folding
8. Co & Post Translational Modification
B] Enzyme Mediated :
E.g. Prolyl hydroxylase, Peptidyl prolyl
isomerase (PPI), PDI
Protein Disulphide Isomerases (PDI):
Protein disulfide isomerase or PDI is
an enzyme in the ER that catalyzes the
formation and breakage of disulfide
bonds between cysteine residues within
proteins as they fold.
Fig; PDI contains an active-site with two reduced cysteine sulfhydryl (–SH) groups.
The ionized (–S−) form of one of these groups reacts with disulfide (S – S) bonds on
nascent or newly completed proteins to form a disulfide-bonded PDI-
substrate protein intermediate. This generates a free –S− group on the protein, which, in
turn, can react with another disulfide bond in the protein to form a new disulfide bond
and another free –S− group. In this way, the disulfide bonds on a protein can rearrange
themselves until the most stable conformation for the protein is achieved, and free PDI
is released.
9. II] Cleavage
Cleavage is one of the
important step in maturation
of many proteins.
Co-Translational Cleavage: It
may occur for the removal of
signal sequences or for the
removal of initiator amino
acids.
Co & Post Translational Modification
Fig: Removal of initiator amino acid in
a) Prokaryotes b) Eukaryotes
10. Post-Translational Cleavage:
Proteolytic trimming:
Many proteins ( insulin,
collagen) & proteases (
trypsin, chymotrypsin) are
initially synthesized as larger
inactive precursor proteins
which are proteolytically
trimmed to produce their
active final forms. This
process is also called as
protein splicing.
Co & Post Translational Modification
11. III] Addition Of Functional Group
Co & Post Translational Modification
Compartment Modification
Nucleus Acetylation(Histone), Phosphorylation
Lysosome Mannose 6Phosphate labeled N-linked
sugar
Mitochondria N-formyl Acylation
Chloroplast N-formyl Acylation
Golgi body N & O-linked Glycosylation
(oligosaccharide),Sulfation, Palmitoylation
ER N-linked Glycosylation(oligosaccharide),
GPI anchor
Cytosol Acetylation, Methylation, Phosphorylation
Ribosome Myristoylation
Plasma membrane N & O-linked Glycosylation, GPI anchor
Extracellular fluid N & O-linked Glycosylation, Acetylation,
Phosphorylation, Hydroxylation
12. a) Chemical groups:
Co & Post Translational Modification
Chemical groups Amino acid Function
1] Glycosylation arginine, asparagine, cystei
ne,
hydroxylysine, serine,
threonine, tyrosine, or
tryptophan
Carbohydrates in the form of
aspargine-linked
(N-linked) or serine/threonine-
linked (O-linked)
oligosaccharides are major
structural components of many
cell surface and secreted proteins
2] Phosphorylation serine, threonine, tyrosine
(O-linked), or histidine
(N-linked)
Reversible, regulation of many
cellular processes including cell
cycle, growth, apoptosis and
signal transduction pathways.
3] Methylation Lysine, glutamine etc Methylation is a well-known
mechanism of
epigenetic regulation, as histone
methylation and demethylation
13. Co & Post Translational Modification
Fig: Glycosylation of protein in
ER
b) Lipidation: Proteins are covalently modified with a variety of lipids,
including fatty acids, isoprenoids, and cholesterol. Lipidation is a method
to target proteins to membranes in organelles (endoplasmic reticulum
[ER], Golgi apparatus, and mitochondria), vesicles (endosomes,
lysosomes) and the plasma membrane.
14. Co & Post Translational Modification
Modification Group attached Enzyme involved Significance
N Myristoylation:
Covalent attachment
of
myristate to an N-
terminal
glycine (commonly)
Myristate (C14
fatty acid)
N-myristoyl
-transferase (NMT)
Co-translational,
irreversible
Membrane targeting
& signal
Transduction. E.g.
Src-family kinases,
are N-myristoylated.
Palmitoylation:
thioester
linkage of palmitate
to
cytoplasmic cysteine
residues.
Palmitate ( C16
Fatty acid)
palmitoyl acyl
transferases (PATs)
Reversible, on/off
switch to
regulate
membrane
localization,
strengthen other
types of lipidation,
such as
myristoylation or
farnesylation
15. Prenylation:
thioether linkage
Of an
isoprenoidlipid to
specific cysteine
residues
within 5 amino
acids from the
C-terminus.
farnesyl (C15) or
geranylgeranyl
(C20)
farnesyl
transferase
(FT) or
geranylgerany
l
transferases
(GGT I and
II)
Irreversible, anchor
protein to
membrane, e.g. all
members of the Ras
superfamily
GPI anchored:
linkage of
glycosyl-
phosphatidylinositol
(GPI) to the C-
terminus of
extracellular proteins
glycosyl-phosphatid
-ylinositol (a
Glycolipid)
Reversible, anchors
protein to
external face of plasma
membrane often localized
to
cholesterol- and
sphingolipid-
rich lipid rafts, which act
as
signaling platforms on the
plasma membrane.
Co & Post Translational Modification
16. Co & Post Translational Modification
Fig; Glycosylphosphatidylinositol
(GPI) anchors contain two fatty acid
chains, an oligosaccharide portion
consisting of inositol and other sugars,
and ethanolamine. The GPI anchors are
assembled in the ER and added to
polypeptides anchored in the membrane
by a carboxy-terminal membrane-
spanning region. The membrane
spanning region is cleaved, and the new
carboxy terminus is joined to the
NH2 group of ethanolamine
immediately after translation is
completed, leaving the protein attached
to the membrane by the GPI anchor.
17. IV] Protein Degradation
Levels of protein within cells are determined not only by rates of
synthesis but also by rates of degradation.
In eukaryotic cells, two major pathways—the ubiquitin-
proteasome pathway and lysosomal proteolysis—mediate protein
degradation.
The major pathway of selective protein degradation in eukaryotic
cells uses ubiquitin as a marker that targets cytosolic and
nuclear proteins by the attachment of ubiquitin to the amino group
of the side chain of a lysine residue for rapid proteolysis.
Ubiquitin is a 76-amino-acid polypeptide that is highly conserved
in all eukaryotes (yeasts, animals, and plants).
E.g.: 1] Degradation of cyclin B by ubiquitin allowing cell to exit
mitosis & enter interphase again.
2] Serves as marker for endocytosis.
Co & Post Translational Modification
18. Co & Post Translational Modification
1] Ubiquitin is activated by being attached to the
ubiquitin-activating enzyme, E1.
2] The ubiquitin is then transferred to a second
enzyme, called ubiquitin conjugating enzyme
(E2)
3] The final transfer of ubiquitin to the target
protein is then mediated by a third enzyme,
called ubiquitin ligase or E3, which is responsible
for the selective recognition of
appropriate substrate proteins.
Additional ubiquitins are then added to form a
multiubiquitin chain. Such polyubiquinated
proteins are recognized and degraded by a large,
multisubunit protease complex, called
the proteasome.
Ubiquitin is released in the process, so it can be
reused in another cycle. It is noteworthy that both
the attachment of ubiquitin and the degradation
of marked proteins require energy in the form of
ATP.
19. B] Lysosomal Proteolysis
The other major pathway of
protein degradation
in eukaryotic cells involves
the uptake of proteins by
lysosomes.
Lysosomes are membrane-
enclosed organelles that
contain an array of
digestive enzymes, including
several proteases.
Co & Post Translational Modification
20. Co & Post Translational Modification
Cell & Molecular Biology
5th edition
Gerald Karp
Molecular Cell Biology 6th
edition
Harvey Lodish
The Cell A Molecular
Approach
4th edition
Geoffrey M Cooper
Internet sources